Healthy Prognosis for Diagnostic and Imaging Companies

Diagnostics and imaging—the very mention of these two fields once made venture capitalists shudder. Historically, neither offered an opportunity to generate true "venture style" returns. With business models that were deemed undefined or capital costs that were too onerous, the pair largely were orphaned by life sciences venture investors who preferred investing in companies that sought to cure maladies, not merely identify them.